where's the great news? We have known the device was safe for 5 years.
The excuse for lack of data is so incredibly lame that I am shocked. A management team knows that what investors absolutely must have is data, and their excuse is that they can't get permission to use it until some later date? Wow.
Not really. Volume is low relative to short interest. Retailers got caught up in the excitement in the first half hour but there is still plenty of time before anything happens here.
I'm out of it. that was the first 50 contract trade this morning. Not enough given the contract expires next week.
lol. They have shown almost zero progress in a year, and you guys are excited about it. This is about as far from SOC that you can get, absolutely no momentum in terms of take rates, no one is clamoring to use the device. Period.
Actually the chart says it's much more likely that this will retest $5 before it ever sees $8. But who's counting....
The only thing stupider than the mindless pumping on this board is the insinuation that if only the CEO put out more pump releases that the stock would go up.
Compare my track record to yours. Always right? certainly not. More often than not, however, and that is how you make money, not being a permabull like yourself.
Keep telling yourself that. There are very good reasons for the under-performance. Your rose-colored glasses just prevent you from hearing them.
What? First time I have ever heard a shelf being referenced as analogous to a poison pill. Read up on your corporate finance, it might do you some good.
In all likelihood this is Gunton from NJTC. This was telegraphed via his board resignation and should be a surprise to absolutely no one that has been paying attention. I told everyone that this would happen when he resigned.
Stop the scaremongering though. A transfer of shares from NJTC to real institutional investors can be a long term positive.